WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Earnings & Revenue

ADPT past revenue growth

How has ADPT's revenue growth performed historically?
Company
-8.11%
Industry
148.4%
Market
16.96%
ADPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADPT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADPT earnings and revenue history

Current Revenue
$170.3M
Current Earnings
-$225.3M
Current Profit Margin
-132.3%

ADPT Return on Equity

Current Company
-60.5%
Current Industry
-63.5%
Current Market
188%
ADPT's Return on Equity (-60.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADPT announces earnings.

ADPT Return on Assets

Current Company
-30.7%
Current Industry
2.9%
ADPT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADPT Return on Capital Employed

Current Company
-36.89%
Current Industry
19.5%
ADPT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADPT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADPT$170.28M-$182.30M-$225.25M+25.06%N/A
FBLG$0.00-$15.90M-$19.06MN/AN/A
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
CRBP$0.00-$41.04M-$44.60M-100.00%N/A
ANRO$0.00-$34.28M-$36.31M-100.00%N/A

ADPT earnings dates

Next earnings date
May 7, 2024

Adaptive Biotechnologies Earnings & Revenue FAQ

What were ADPT's earnings last quarter?

On Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 2023 earnings per share (EPS) of -$0.48, up 71.43% year over year. Total Adaptive Biotechnologies earnings for the quarter were -$69.44 million. In the same quarter last year, Adaptive Biotechnologies's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.

What was ADPT's earnings growth in the past year?

As of Q2 2024, Adaptive Biotechnologies's earnings has grown year over year. Adaptive Biotechnologies's earnings in the past year totalled -$225.25 million.

What is ADPT's earnings date?

Adaptive Biotechnologies's earnings date is Invalid Date. Add ADPT to your watchlist to be reminded of ADPT's next earnings announcement.

What was ADPT's revenue last quarter?

On Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 2023 revenue of $45.78 million up 17.05% year over year. In the same quarter last year, Adaptive Biotechnologies's revenue was $55.20 million.

What was ADPT's revenue growth in the past year?

As of Q2 2024, Adaptive Biotechnologies's revenue has grown -8.11% year over year. This is 156.52 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Adaptive Biotechnologies's revenue in the past year totalled $170.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.